Published in Can J Infect Dis on January 01, 1990
A case of emphysematous osteomyelitis of the midfoot: imaging findings and review of the literature. Case Rep Radiol (2014) 0.79
THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN. J Exp Med (1935) 2.09
Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis (1983) 2.00
Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. J Infect (1988) 1.35
Septic arthritis due to group G streptococcus. JAMA (1982) 1.03
Occurrence and characterization of Lancefield group G streptococci in bovine mastitis. Am J Vet Res (1970) 1.02
Spontaneous Lancefield group G streptococcal infection in a random source cat colony. Lab Anim Sci (1973) 1.01
An attempt to classify Streptococcic isolates from domestic animals. Am J Vet Res (1965) 0.94
Bone and joint infections in intravenous drug abusers. Rev Infect Dis (1987) 0.86
Beta hemolytic streptococcal endocarditis: predominance of non-group A organisms. Am J Med Sci (1979) 0.85
Importance of group G streptococci in human pyogenic infections. J Trop Med Hyg (1989) 0.85
An epizootic of necrotic dermatitis in laboratory mice caused by Lancefield group G streptococci. Lab Anim Sci (1975) 0.84
Group G streptococci as a cause of bacterial endophthalmitis. Case report. Arch Ophthalmol (1988) 0.81
Group G streptococcal bacteremia in a healthy young man. South Med J (1989) 0.80
An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. J Immunol (1976) 3.14
Intraocular treponemes in treated congenital syphilis. Arch Ophthalmol (1967) 2.74
Locus of the lethal event in the serum bactericidal reaction. J Bacteriol (1968) 2.35
FTA-ABS and VDRL slide test reactivity in a population of nuns. JAMA (1971) 2.17
Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction. J Bacteriol (1968) 1.99
Serial ultrathin sectioning demonstrating the intracellularity of T. Pallidum. An electron microscopic study. Br J Vener Dis (1972) 1.98
The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli. J Immunol (1969) 1.87
Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9. J Immunol (1972) 1.59
The relationship between morphology and transparency in the nonswelling corneal stroma of the shark. Invest Ophthalmol (1967) 1.44
The basement membrane of the human cornea in recurrent epithelial erosion syndrome. Trans Am Acad Ophthalmol Otolaryngol (1969) 1.17
Structural alterations affecting transparency in swollen human corneas. Invest Ophthalmol (1968) 1.11
Reaction mechanisms of nascent C567 (reactive lysis). II. Killing of a rough form of Escherichia coli by C567, C8, and C9. J Infect Dis (1974) 1.04
Histopathology of corneal edema. Int Ophthalmol Clin (1968) 0.96
Functional and biochemical properties of the early classical complement system of mice. J Immunol (1978) 0.94
Relationship of functional levels of early components of complement to the H-2 complex of mice. J Immunol (1976) 0.92
Use of protein A--containing Staphylococcus aureus as an immunoadsorbent in radioimmunoassays to separate antibody-bound from free antigen. J Lab Clin Med (1979) 0.90
Fluorescent antibody staining of treponemes in uveitis. Arch Ophthalmol (1968) 0.89
A fluorescent compound in collagen and its relation to the age of the animal. Exp Gerontol (1970) 0.88
Anterior Chamber Depth in Aphakia. Trans Am Ophthalmol Soc (1963) 0.87
Ampicillin, erythromycin and chloramphenicol penetration into rabbit aqueous humor. Ann Ophthalmol (1973) 0.86
Murine sex-limited protein expression requires androgens and pituitary hormones. Immunogenetics (1986) 0.85
Immunochemical properties of the murine Ss protein. J Immunol (1978) 0.84
Reactions of nascent C567 (reactive lysis). Transplant Proc (1974) 0.82
Activation of murine complement by cobra venom factor in the presence of EDTA. J Immunol (1979) 0.79
Immunologic control of C3 gene expression in tissue macrophages. J Immunol (1991) 0.79
Measles virus persistence in an immortalized murine macrophage cell line. Virology (1995) 0.79
Cytologic and histochemical changes in corneal wound repair. Arch Ophthalmol (1966) 0.78
Glycosaminoglycans in the nonswelling corneal stroma of dogfish shark. Invest Ophthalmol (1970) 0.78
Antibody-induced suppression of the fifth component of complement in mice. J Immunol (1978) 0.77
T lymphocytes mediate immunologic control of C3 gene expression. Eur J Immunol (1992) 0.77
The role of lymphoid cells in antibody-induced suppression of the fourth component of guinea pig complement. Cell Immunol (1987) 0.77
Cell-mediated suppression of the fifth component of complement in mice. J Immunol (1979) 0.77
Enhancement by cyclic AMP of antibody-induced suppression of the fourth component of complement. J Immunol (1985) 0.76
Antibody-induced suppression and postsuppression stimulation of complement in vitro. 1. Effects of anti-c4 on cultured guinea pig peritoneal cells. Cell Immunol (1982) 0.76
Clinical experience with amicillin and probenecid in the management of treponeme-associated uveitis. Trans Am Acad Ophthalmol Otolaryngol (1970) 0.76
Antibody-induced suppression and postsuppression stimulation of complement in vitro. III. Long-term C4 suppression is actively maintained by a soluble suppressor factor (FsC4). Cell Immunol (1985) 0.76
The intraocular penetration of chloramphenicol succinate in rabbits. Ann Ophthalmol (1973) 0.76
Suppression of measles virus expression by noncytolytic antibody in an immortalized macrophage cell line. J Virol (1995) 0.76
Enhancement of macrophage survival and complement production by factors from cloned T cells. Complement (1984) 0.75
What the clinician should know about the major histocompatibility complex. JAMA (1981) 0.75
Immune regulation of complement components in vivo. Cell Immunol (1982) 0.75
[Causes of opacity after corneal graft in interestitial keratitis]. Bull Mem Soc Fr Ophtalmol (1967) 0.75
Functional and developmental differences between genetically controlled phenotypes of the sixth component of complement in rabbits. J Immunol (1982) 0.75
The genetics of antibody production. Clinical implications. JAMA (1984) 0.75
Genetic control of C6 polymorphism and C6 deficiency in rabbits. J Immunol (1982) 0.75
Cytology of four yeastlike organisms in tissue explants. Mycopathol Mycol Appl (1966) 0.75